Cargando…

Which symptoms contribute the most to patients’ perception of health in multiple sclerosis?

BACKGROUND: Multiple sclerosis is a polysymptomatic disease. Little is known about relative contributions of the different multiple sclerosis symptoms to self-perception of health. OBJECTIVES: To investigate the relationship between symptom severity in 11 domains affected by multiple sclerosis and s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, Rivka, Cutter, Gary, Friendly, Michael, Kister, Ilya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588807/ https://www.ncbi.nlm.nih.gov/pubmed/28904811 http://dx.doi.org/10.1177/2055217317728301

Ejemplares similares

How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity
por: Kister, Ilya, et al.
Publicado: (2021)

Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment era
por: Kister, Ilya, et al.
Publicado: (2018)

Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items
por: Chamot, Eric, et al.
Publicado: (2014)

Perceptions of physical activity guidelines among wheelchair users with multiple sclerosis
por: Silveira, Stephanie L., et al.
Publicado: (2022)

Infection Mitigation Strategies for Multiple Sclerosis Patients on Oral and Monoclonal Disease-Modifying Therapies
por: Smith, Tyler Ellis, et al.
Publicado: (2021)

Health Literacy Association With Health Behaviors and Health Care Utilization in Multiple Sclerosis: A Cross-Sectional Study
por: Marrie, Ruth Ann, et al.
Publicado: (2014)

Preferred Sources of Health Information in Persons With Multiple Sclerosis: Degree of Trust and Information Sought
por: Marrie, Ruth Ann, et al.
Publicado: (2013)

Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2019)

Track density imaging of hypertrophic olivary degeneration from multiple sclerosis plaque
por: Hoch, Michael J, et al.
Publicado: (2016)

Clinical trials in multiple sclerosis: milestones
por: Zhang, Yinan, et al.
Publicado: (2018)

No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple Sclerosis: Symptom Burden on Ocrelizumab: A Longitudinal Study (SymBOLS)
por: Kister, Ilya, et al.
Publicado: (2023)

Evolution of clinical trials in multiple sclerosis
por: Zhang, Yinan, et al.
Publicado: (2019)

Serious safety events in rituximab‐treated multiple sclerosis and related disorders
por: Vollmer, Brandi L., et al.
Publicado: (2020)

The timed 25-foot walk in a large cohort of multiple sclerosis patients
por: Kalinowski, Anissa, et al.
Publicado: (2021)

Coping with Multiple Virulence Factors: Which Is Most Important?
por: McClelland, Erin E, et al.
Publicado: (2005)

Which Health Systems Provide the Most Health?
por: Braithwaite, R. Scott
Publicado: (2020)

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Periventricular Lesions Help Differentiate Neuromyelitis Optica Spectrum Disorders from Multiple Sclerosis
por: Raz, Eytan, et al.
Publicado: (2014)

Diet Quality Assessment in Wheelchair Users with Multiple Sclerosis
por: Silveira, Stephanie L., et al.
Publicado: (2021)

Which factors contribute most to genome size variation within angiosperms?
por: Wang, Dandan, et al.
Publicado: (2021)

Which exercise and behavioural interventions show most promise for treating fatigue in multiple sclerosis? A network meta-analysis
por: Harrison, Anthony M, et al.
Publicado: (2021)

Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
por: Ntentas, Georgios, et al.
Publicado: (2019)

Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging
por: Chawla, Sanjeev, et al.
Publicado: (2018)

MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis
por: Koch, Marcus W, et al.
Publicado: (2021)

Contributing Factors to the Quality of Life in Multiple Sclerosis
por: Sehanovic, Aida, et al.
Publicado: (2020)

Uptake and Attitudes About Immunizations in People With Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Mortality in neuromyelitis optica is strongly associated with African ancestry
por: Mealy, Maureen A., et al.
Publicado: (2018)

National estimates of self-reported sitting time in adults with multiple sclerosis
por: Sasaki, JE, et al.
Publicado: (2018)

Attitudes of people with multiple sclerosis toward brain donation
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Which factor contribute most to empower farmers through e-Agriculture in Bangladesh?
por: Rashid, Sheikh Mohammed Mamur, et al.
Publicado: (2016)

Plasticity after perceptual narrowing for voice perception: reinstating the ability to discriminate monkeys by their voices at 12 months of age
por: Friendly, Rayna H., et al.
Publicado: (2013)

Effectiveness of film as a health communication tool to improve perceptions and attitudes in multiple sclerosis
por: Chiong-Rivero, Horacio, et al.
Publicado: (2021)

The Exacerbation of Chronic Obstructive Pulmonary Disease: Which Symptom is Most Important to Monitor?
por: Jacobson, Petra Kristina, et al.
Publicado: (2023)

Physical and Mental Health–Related Quality of Life Trajectories Among People With Multiple Sclerosis
por: O'Mahony, Julia, et al.
Publicado: (2022)

Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?
por: van Deutekom, Hanneke W. M., et al.
Publicado: (2015)

The contribution of self-disclosure to the prediction of mood symptoms in patients with multiple sclerosis
por: Mahboobi, Marzieh, et al.
Publicado: (2021)

Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course
por: Kister, Ilya, et al.
Publicado: (2010)

Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree
por: Cutter, Gary R., et al.
Publicado: (2016)

Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset
por: Koch, Marcus W, et al.
Publicado: (2023)

Communicating with parents of obese children: which channels are most effective?
por: Randle, Melanie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9g9574fmqcrsebmp69cav5f25p